MENU
JUN 17, 2020 1:30 PM PDT

Insights into the Pathogenesis of COVID-19 as Revealed by Spatial Biology

Sponsored by: NanoString Technologies
C.E. Credits: P.A.C.E. CE Florida CE
Speakers

Abstract

Understanding the complex interplay between a pathogen and the host response is important to developing effective vaccines and therapeutics. The nCounter® Analysis System and GeoMx® Digital Spatial Profiler (DSP) from NanoString enable researchers to rapidly perform high-plex experiments in key areas of biology that answer questions related to the effect of pathogen infection at the molecular, cellular, tissue, and individual level. The nCounter has been utilized in hundreds of publications on pathogens and the associated host response, including in several recent studies on COVID-19.

NanoString has developed an 1,800+ RNA panel for GeoMx DSP to facilitate spatial gene expression profiling of the SARs-CoV-2 virus and host response and is currently developing a five-antibody custom protein module for spatial protein analysis. These assays will include SARs-CoV-2 viral markers and the ACE2 receptor, among other receptors, proteases, cell markers, and viral response markers.

In this webinar, Joseph Beechem, Ph.D., NanoString Chief Scientific Officer & Senior Vice President, Research and Development, will open by summarizing recent insights into how the host responds to SARs-CoV-2 and Christopher E. Mason, Ph.D., Associate Professor Weill Cornell Medicine, will conclude by discussing a recent investigation into spatial gene expression differences seen in COVID-19 lung tissue vs. non-COVID-19 lung tissue and healthy controls.

Learning Objectives:

1. Learn how bulk gene expression assays and spatial biology can be used to study COVID-19

2. Understand how the host immune system responds to SARs-CoV-2 infection

3. Learn about gene expression changes seen in COVID-19 lung samples vs. healthy controls


Show Resources
You May Also Like
MAY 17, 2022 9:00 AM PDT
MAY 17, 2022 9:00 AM PDT
Date: May 17, 2022 Time: 9:00am (PDT), 12:00pm (EDT), 8:00pm (CEST) Gene therapeutics have great potential to treat many severe diseases in an unprecedented, targeted manner. The biopharmace...
MAR 23, 2022 11:00 AM PDT
MAR 23, 2022 11:00 AM PDT
Date: March 23, 2021 Time: 11:00am (PDT), 2:00pm (EDT), 8:00pm (CEDT) In this presentation, Dr. Middleton will review the development and deployment of large-scale saliva-based COVID-19 test...
NOV 30, 2021 10:00 AM PST
C.E. CREDITS
NOV 30, 2021 10:00 AM PST
Date: November 30, 2021 Time: 10:00am (PDT), 1:00pm (EDT) The prevalence of thyroid disease worldwide has served as a catalyst for healthcare providers to study various tools and methods to...
DEC 09, 2021 11:00 AM PST
C.E. CREDITS
DEC 09, 2021 11:00 AM PST
Date: December 09, 2021 Time: 11:00am (PDT), 2:00pm (EDT) The burden of antimicrobial resistance (AMR) has been acknowledged worldwide by leading health institutes. Besides the need for new...
MAR 16, 2022 8:00 AM PDT
C.E. CREDITS
MAR 16, 2022 8:00 AM PDT
Date: March 16, 2022 Time: 8:00am (PDT), 11:00am (EDT), 5:00pm (CET) Handling of potent and/or hazardous substances is commonplace in sev.....
MAR 02, 2022 9:00 AM PST
C.E. CREDITS
MAR 02, 2022 9:00 AM PST
Date: March 02, 2022 Time: 9:00am (PST), 12:00pm (EST) Single cell RNA-seq is known to only capture a small fraction of the transcriptome of each cell. Often, this is due to inherent limitat...
Loading Comments...
Show Resources